+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Grifols, S.A. - logo

Grifols is a leading producer of plasma-derived protein therapies for patients who have rare, genetic diseases and life-threatening infections. They are currently the largest supplier of source plasma for plasma therapy production in the world. They have built a network of 147 plasma donation centers throughout the United States and their annual plasma collection exceeds 6.5 million liters. Grifols, S.A. was founded in 1940 and is headquartered in Barcelona, Spain.

Tetanus Toxoid Vaccine Market 2025-2029 - Product Thumbnail Image

Tetanus Toxoid Vaccine Market 2025-2029

  • Report
  • June 2025
  • 200 Pages
  • Global
From
From
From
Human Combination Vaccines Market 2025-2029 - Product Thumbnail Image

Human Combination Vaccines Market 2025-2029

  • Report
  • May 2025
  • 222 Pages
  • Global
From
Global Markets for Blood Plasma Products - Product Thumbnail Image

Global Markets for Blood Plasma Products

  • Report
  • February 2023
  • 144 Pages
  • Global
From
From
From
From
Licensing Deals in Biotechnology 2020-2026 - Product Thumbnail Image

Licensing Deals in Biotechnology 2020-2026

  • Report
  • March 2026
  • 1100 Pages
  • Global
From
Bleeding Disorders Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bleeding Disorders Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Blood Plasma Derivatives Market - Global Forecast 2026-2032 - Product Thumbnail Image

Blood Plasma Derivatives Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
From
Plasma Fractionation Market 2025-2029 - Product Thumbnail Image

Plasma Fractionation Market 2025-2029

  • Report
  • August 2025
  • 214 Pages
  • Global
From
Blood Market 2025-2029 - Product Thumbnail Image

Blood Market 2025-2029

  • Report
  • June 2025
  • 226 Pages
  • Global
From
Loading Indicator